Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke

James F Meschia, Thomas G Brott, Robert D Jr. Brown, Richard Crook, Bradford B. Worrall, Brett Kissela, W. Mark Brown, Stephen S. Rich, L. Douglas Case, E. Whitney Evans, Stephen Hague, Andrew Singleton, John Hardy

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Risk for ischemic stroke is mediated by both environmental and genetic factors. Although several environmental exposures have been implicated, relatively little is known about the genetic basis of predisposition to this disease. Recent studies in Iceland identified risk polymorphisms in two putative candidate genes for ischemic stroke: phosphodiesterase 4D (PDE4D) and 5-lipoxygenase activating protein (ALOX5AP). A collection of North American sibling pairs concordant for ischemic stroke and two cohorts of prospectively ascertained North American ischemic stroke cases and control subjects were used for evaluation of PDE4D and ALOX5AP. Although no evidence supported linkage of ischemic stroke with either of the two candidate genes, single-nucleotide polymorphisms and haplotypic associations were observed between PDE4D and ischemic stroke. There was no evidence of association between variants of ALOX5AP and ischemic stroke. These data suggest that common variants in PDE4D may contribute to the genetic risk for ischemic stroke in multiple populations.

Original languageEnglish (US)
Pages (from-to)351-361
Number of pages11
JournalAnnals of Neurology
Volume58
Issue number3
DOIs
StatePublished - Sep 2005

Fingerprint

5-Lipoxygenase-Activating Proteins
Type 4 Cyclic Nucleotide Phosphodiesterase
Type 5 Cyclic Nucleotide Phosphodiesterases
Stroke
Iceland
Environmental Exposure
Genetic Predisposition to Disease
Genes
Single Nucleotide Polymorphism

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. / Meschia, James F; Brott, Thomas G; Brown, Robert D Jr.; Crook, Richard; Worrall, Bradford B.; Kissela, Brett; Brown, W. Mark; Rich, Stephen S.; Case, L. Douglas; Evans, E. Whitney; Hague, Stephen; Singleton, Andrew; Hardy, John.

In: Annals of Neurology, Vol. 58, No. 3, 09.2005, p. 351-361.

Research output: Contribution to journalArticle

Meschia, JF, Brott, TG, Brown, RDJ, Crook, R, Worrall, BB, Kissela, B, Brown, WM, Rich, SS, Case, LD, Evans, EW, Hague, S, Singleton, A & Hardy, J 2005, 'Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke', Annals of Neurology, vol. 58, no. 3, pp. 351-361. https://doi.org/10.1002/ana.20585
Meschia, James F ; Brott, Thomas G ; Brown, Robert D Jr. ; Crook, Richard ; Worrall, Bradford B. ; Kissela, Brett ; Brown, W. Mark ; Rich, Stephen S. ; Case, L. Douglas ; Evans, E. Whitney ; Hague, Stephen ; Singleton, Andrew ; Hardy, John. / Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. In: Annals of Neurology. 2005 ; Vol. 58, No. 3. pp. 351-361.
@article{98ff8e04441a40caa984572570ef84e9,
title = "Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke",
abstract = "Risk for ischemic stroke is mediated by both environmental and genetic factors. Although several environmental exposures have been implicated, relatively little is known about the genetic basis of predisposition to this disease. Recent studies in Iceland identified risk polymorphisms in two putative candidate genes for ischemic stroke: phosphodiesterase 4D (PDE4D) and 5-lipoxygenase activating protein (ALOX5AP). A collection of North American sibling pairs concordant for ischemic stroke and two cohorts of prospectively ascertained North American ischemic stroke cases and control subjects were used for evaluation of PDE4D and ALOX5AP. Although no evidence supported linkage of ischemic stroke with either of the two candidate genes, single-nucleotide polymorphisms and haplotypic associations were observed between PDE4D and ischemic stroke. There was no evidence of association between variants of ALOX5AP and ischemic stroke. These data suggest that common variants in PDE4D may contribute to the genetic risk for ischemic stroke in multiple populations.",
author = "Meschia, {James F} and Brott, {Thomas G} and Brown, {Robert D Jr.} and Richard Crook and Worrall, {Bradford B.} and Brett Kissela and Brown, {W. Mark} and Rich, {Stephen S.} and Case, {L. Douglas} and Evans, {E. Whitney} and Stephen Hague and Andrew Singleton and John Hardy",
year = "2005",
month = "9",
doi = "10.1002/ana.20585",
language = "English (US)",
volume = "58",
pages = "351--361",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke

AU - Meschia, James F

AU - Brott, Thomas G

AU - Brown, Robert D Jr.

AU - Crook, Richard

AU - Worrall, Bradford B.

AU - Kissela, Brett

AU - Brown, W. Mark

AU - Rich, Stephen S.

AU - Case, L. Douglas

AU - Evans, E. Whitney

AU - Hague, Stephen

AU - Singleton, Andrew

AU - Hardy, John

PY - 2005/9

Y1 - 2005/9

N2 - Risk for ischemic stroke is mediated by both environmental and genetic factors. Although several environmental exposures have been implicated, relatively little is known about the genetic basis of predisposition to this disease. Recent studies in Iceland identified risk polymorphisms in two putative candidate genes for ischemic stroke: phosphodiesterase 4D (PDE4D) and 5-lipoxygenase activating protein (ALOX5AP). A collection of North American sibling pairs concordant for ischemic stroke and two cohorts of prospectively ascertained North American ischemic stroke cases and control subjects were used for evaluation of PDE4D and ALOX5AP. Although no evidence supported linkage of ischemic stroke with either of the two candidate genes, single-nucleotide polymorphisms and haplotypic associations were observed between PDE4D and ischemic stroke. There was no evidence of association between variants of ALOX5AP and ischemic stroke. These data suggest that common variants in PDE4D may contribute to the genetic risk for ischemic stroke in multiple populations.

AB - Risk for ischemic stroke is mediated by both environmental and genetic factors. Although several environmental exposures have been implicated, relatively little is known about the genetic basis of predisposition to this disease. Recent studies in Iceland identified risk polymorphisms in two putative candidate genes for ischemic stroke: phosphodiesterase 4D (PDE4D) and 5-lipoxygenase activating protein (ALOX5AP). A collection of North American sibling pairs concordant for ischemic stroke and two cohorts of prospectively ascertained North American ischemic stroke cases and control subjects were used for evaluation of PDE4D and ALOX5AP. Although no evidence supported linkage of ischemic stroke with either of the two candidate genes, single-nucleotide polymorphisms and haplotypic associations were observed between PDE4D and ischemic stroke. There was no evidence of association between variants of ALOX5AP and ischemic stroke. These data suggest that common variants in PDE4D may contribute to the genetic risk for ischemic stroke in multiple populations.

UR - http://www.scopus.com/inward/record.url?scp=24644505715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644505715&partnerID=8YFLogxK

U2 - 10.1002/ana.20585

DO - 10.1002/ana.20585

M3 - Article

C2 - 16130105

AN - SCOPUS:24644505715

VL - 58

SP - 351

EP - 361

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 3

ER -